QT Imaging (QTI) Projected to Post Quarterly Earnings on Tuesday

QT Imaging (NASDAQ:QTI) is expected to announce its results before the market opens on Tuesday, May 12th. Analysts expect the company to announce earnings of ($0.1350) per share and revenue of $6.4480 million for the quarter.

QT Imaging (NASDAQ:QTI) last announced its quarterly earnings data on Wednesday, February 18th. The company reported ($0.10) EPS for the quarter. The business had revenue of $8.27 million for the quarter. On average, analysts expect QT Imaging to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

QT Imaging Stock Performance

QT Imaging stock traded up $0.17 during trading hours on Tuesday, reaching $6.70. 3,117 shares of the stock were exchanged, compared to its average volume of 34,697. The stock has a market cap of $80.62 million, a P/E ratio of -3.06 and a beta of 0.01. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.17 and a current ratio of 2.81. QT Imaging has a 52-week low of $0.65 and a 52-week high of $8.50. The firm’s 50 day moving average is $6.41 and its 200 day moving average is $5.93.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on QTI shares. Weiss Ratings assumed coverage on shares of QT Imaging in a research report on Thursday, January 29th. They set a “sell (e+)” rating for the company. Zacks Research raised QT Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Lake Street Capital assumed coverage on QT Imaging in a research note on Friday, January 30th. They set a “buy” rating for the company. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, QT Imaging presently has a consensus rating of “Hold”.

About QT Imaging

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.